Net working capital: dealmaker or dealbreaker?
Deal advisoryWhy getting working capital right is critical to deal value

In M&A, adjusted EBITDA is more than just a financial metric - it’s a battleground. While designed to reflect a business's “true” profitability, it often becomes a tug-of-war between seller optimism and buyer scepticism.
Sellers want to paint the rosiest picture possible. Buyers want to ground that picture in reality. So who’s right?
Sellers argue that adjusted EBITDA shows what the business could earn post-transaction - without legacy costs, personal perks, or one-off disruptions. In their view, it’s not about the past; it’s about the potential. They’re selling the ideal future.
On the other hand, buyers are focused on what the business is earning today, not under perfect conditions, but in reality. They want to understand what they’re actually buying. Would the seller still make this adjustment if they were keeping the business?
It’s easy to agree on EBITDA in theory - until both sides start adjusting it. This is where deal tension could build: sellers push for recognition potential while buyers guard against overpaying for optimism. That’s when the real negotiation begins.
Adjusted EBITDA starts with the reported base figure, but quickly diverges as both sides add or remove line items. Here are a few examples of where things may get contentious:
These are just a few examples of adjustments that commonly spark debate. Each adjustment comes with a story told to reshape how the business is perceived. But stories can change depending on who's telling them: seller or buyer, optimist or sceptic. The key questions remain: is the adjustment credible, and does it reflect the future reality of running the business?
Not all adjustments are created equal. Some are valid, backed by documentation, and clearly non-recurring, while others are more speculative.
| Valid | Opportunistic | Grey Area |
|---|---|---|
|
One-time legal settlement (with supporting documentation)
|
Adding back recruitment costs in a high-churn business
|
Pro-forma add-backs for cost savings from a planned move to a smaller facility
|
The key is intent and consistency. Are these adjustments consistently applied and transparently supported? Or are they selectively chosen to shape the valuation narrative?
This is where your financial due diligence team steps in. We challenge and validate assumptions, test the rationale for adjustments, support with underlying proof, and build a neutral version of adjusted EBITDA - grounded in facts and future expectations.
Inflated EBITDA can lead to overvaluation, unrealistic synergies, and poor post-deal performance.
Valuation, purchase price, and even earn-outs are often tied to adjusted EBITDA. Getting it wrong can mean millions lost. The lesson? Don’t just accept adjustments at face value. Interrogate them. Validate them. Normalise them.
Adjusted EBITDA should reflect commercial reality, not the version of the story that benefits just one side.
Contact our Deal Advisory specialists to help you uncover the business's true earnings power beyond the adjustments.
Why getting working capital right is critical to deal value
If you’re preparing to sell or invest in a company, focusing on EBITDA alone can be a costly mistake. Let’s uncover why.